Partner with us

ImmuneWatch is striving for excellence in its field and recognises the importance of strong strategic collaborations to achieve their goals. We are therefore open to partnerships with key international academic institutions and private companies.

Do you want to work with us?

CAPTIVATE, a new innovative European partnership to tackle hurdles in malaria vaccine development. With cutting-edge technologies and an unwavering commitment, the EU-funded CAPTIVATE project has the mission to create a next-generation malaria vaccine that targets multiple stages of the deadliest malaria parasite, P. falciparum.

Launched end of 2023, ImmuneWatch will work together with the European Vaccine Initiative (EVI) (Germany), Leiden University Medical Center (Netherlands), Deutsches Krebsforschungszentrum Heidelberg (Germany),  NEC OncoImmunity (Norway) , Quantoom biosciences (Belgium), Stichting Biomedical Primate Research Center (Netherlands) and University of New South Wales (Australia).

More info here.

Logos of Quantoom Biosciences and University of Antwerp

Early 2023, ImmuneWatch entered into a public-private partnership with Quantoom Biosciences and the University of Antwerp. The goal of this project is to assess if a detailed analysis of the T-cell receptor response can be utilized to inform vaccine design and augment the vaccine development process. It is believed that the proposed methodology could reduce time and expenditures in the preclinical development process of vaccines. As a proof-of-concept, the team has chosen to work on a rabies vaccine candidate.

Connect with us!

Business [at] immunewatch.com

Privacy and cookie policy

Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.

ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium